Christina H Chiang

Title: Christina H Chiang: Innovator in Viral Vector Technology

Introduction

Christina H Chiang is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of viral vector technology, holding a total of 6 patents. Her work focuses on the development of recombinant and mutant adenoviruses, as well as equine herpesviruses, which have important applications in vaccination and gene therapy.

Latest Patents

One of her latest patents involves recombinant and mutant adenoviruses. This invention provides novel viral vectors, including mutant and recombinant bovine adenoviruses with specific deletions and/or insertions of DNA in the early gene regions E4 and E3. These viral vectors are designed for use in vaccination, gene therapy, and other suitable applications. Another significant patent relates to recombinant equine herpesviruses. This invention describes a non-naturally occurring, recombinant equine herpesvirus capable of replication, which incorporates foreign DNA into the equine herpesviral DNA at non-essential sites. This technology also includes methods for producing fetal-safe, live recombinant equine herpesviruses.

Career Highlights

Throughout her career, Christina has worked with notable companies such as Syntro Corporation and Schering-Plough Veterinary Corporation. Her expertise in viral vector technology has positioned her as a leader in her field, contributing to advancements in veterinary medicine and gene therapy.

Collaborations

Christina has collaborated with esteemed colleagues, including Mark D Cochran and Richard D Macdonald. These partnerships have further enhanced her research and development efforts in viral vector technology.

Conclusion

Christina H Chiang is a trailblazer in the field of viral vector technology, with a strong portfolio of patents that reflect her innovative spirit. Her contributions have the potential to impact various applications in medicine and biotechnology.